Press Releases - 2024-06-26

Date	Title	Company
26-Jun-2024	EY Announces Dr. Jin Kim of Rezolut as an Entrepreneur of the Year(R) 2024 Southeast Award Winner	AccessWire
26-Jun-2024	Biotricity to Host Fourth Quarter and Fiscal Year 2024 Financial Results and Business Update Call on June 27	AccessWire
26-Jun-2024	Dental Adhesives Market is expected to grow at a 4.5% CAGR and reach US$3.58 Billion by 2032 \| FMI Research Report	MARKITWIRED
26-Jun-2024	Intraoral Scanners Market is expected to grow at a 7.6% CAGR and reach US$1.5 Billion by 2034 \| FMI Study	MARKITWIRED
26-Jun-2024	Stethoscope Hygiene Devices Market is predicted to grow at a 6.9% annual rate and reach US$ 91.4 Million by 2032 \| FMI	MARKITWIRED
26-Jun-2024	Dental Flap Surgery Market is expected to reach US$ 10.31 Billion by 2032 at a compound annual growth rate of 7.5% \| FMI Study	MARKITWIRED
26-Jun-2024	Inhalation and Nasal Spray Generic Drugs Market is expected to grow explosively at a rate of 8.96% CAGR and reach US$49 Billion by 2033 \| FMI	MARKITWIRED
26-Jun-2024	Handheld Dental X-rays System Market is anticipated to be valued US$ 397.1 Million By 2032, expand at a CAGR of 6.4%	MARKITWIRED
26-Jun-2024	Dentures Market is anticipated to expand at a 6.7% CAGR and reach an astounding US$3.2 Billion by 2032 \| FMI	MARKITWIRED
26-Jun-2024	Monoclonal Antibodies Market is expected to reach US$ 648.01 Billion, growing at a CAGR of 12% By 2032 \| FMI	MARKITWIRED
26-Jun-2024	Pupillometer Market is expected to reach a valuation of US$809.56 Million by 2033, With a stable 7.7% CAGR \| FMI Analysis	MARKITWIRED
26-Jun-2024	Wheelchairs Market is predicted to reach USD 9,804.9 Million by 2034, a steady CAGR of 3.4% \| FMI Study	MARKITWIRED
26-Jun-2024	Regenerative Artificial Skin Market is projected to grow at a CAGR of 9.9%, to reach US$ 5,615.5 Million By 2032 \| FMI	MARKITWIRED
26-Jun-2024	Quadriplegia Treatment Market expected to reach US$ 2,324.4 Million by 2032 at a 4.7% CAGR \| FMI Insights	MARKITWIRED
26-Jun-2024	Discovery Park Innovation Summit showcases Kent’s ambition to be a leader in healthy ageing	Discovery Park
26-Jun-2024	EDX MEDICAL TO MARKET PIONEERING CANCER DRUGS RESPONSE ASSAY IN UK AND NORDICS	EDX Medical Group
26-Jun-2024	NICE ENABLES ACCESS TO FIRST TREATMENT THAT TARGETS THE UNDERLYING PATHOPHYSIOLOGY OF RARE DISEASE X-LINKED HYPOPHOSPHATAEMIA (XLH) IN ADULTS1	Kyowa Kirin
26-Jun-2024	Mim8 demonstrated superior reductions in annualised bleeding rate (ABR) compared to on-demand and prior prophylaxis treatment in people with haemophilia A	Novo Nordisk
26-Jun-2024	Stirling Anglian Pharmaceuticals launches new website with focus on providing patients with value-based solutions to healthcare	Anglian Pharmaceuticals l
26-Jun-2024	NICE recommends Eladynos®▼ (abaloparatide) for treating osteoporosis in postmenopausal women	Theramex